BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2735457)

  • 1. Intraventricular CCK inhibits food intake and gastric emptying in baboons.
    Figlewicz DP; Sipols AJ; Porte D; Woods SC; Liddle RA
    Am J Physiol; 1989 Jun; 256(6 Pt 2):R1313-7. PubMed ID: 2735457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraventricular CCK-8 reduces single meal size in the baboon by interaction with type-A CCK receptors.
    Figlewicz DP; Nadzan AM; Sipols AJ; Green PK; Liddle RA; Porte D; Woods SC
    Am J Physiol; 1992 Oct; 263(4 Pt 2):R863-7. PubMed ID: 1415799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological role for cholecystokinin in reducing postprandial hyperglycemia in humans.
    Liddle RA; Rushakoff RJ; Morita ET; Beccaria L; Carter JD; Goldfine ID
    J Clin Invest; 1988 Jun; 81(6):1675-81. PubMed ID: 3290250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cholecystokinin on gastric motility in humans.
    Beglinger C
    Ann N Y Acad Sci; 1994 Mar; 713():219-25. PubMed ID: 8185162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IVT CCK-8 is more effective than IV CCK-8 at decreasing meal size in the baboon.
    Figlewicz DP; Sipols AJ; Green P; Porte D; Woods SC
    Brain Res Bull; 1989 May; 22(5):849-52. PubMed ID: 2765945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of cholecystokinin-octapeptide (CCK-8) on food intake and gastric emptying in man.
    Muurahainen N; Kissileff HR; Derogatis AJ; Pi-Sunyer FX
    Physiol Behav; 1988; 44(4-5):645-9. PubMed ID: 3237850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent and sustained satiety actions of a cholecystokinin octapeptide analogue.
    Moran TH; Sawyer TK; Seeb DH; Ameglio PJ; Lombard MA; McHugh PR
    Am J Clin Nutr; 1992 Jan; 55(1 Suppl):286S-290S. PubMed ID: 1728841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of actions of cholecystokinin octapeptide on food intake and insulin and pancreatic polypeptide release in the dog.
    Inui A; Okita M; Inoue T; Sakatani N; Oya M; Morioka H; Ogawa T; Mizuno N; Baba S
    Peptides; 1988; 9(5):1093-100. PubMed ID: 3072534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNS injection of CCK in rats: effects on real and sham feeding and gastric emptying.
    Della-Fera MA; Coleman BD; Baile CA
    Am J Physiol; 1990 May; 258(5 Pt 2):R1165-9. PubMed ID: 2337197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous cholecystokinin does not decrease food intake or gastric emptying in fasted rats.
    Smith GP; Greenberg D; Falasco JD; Avilion AA; Gibbs J; Liddle RA; Williams JA
    Am J Physiol; 1989 Dec; 257(6 Pt 2):R1462-6. PubMed ID: 2604005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of gastric emptying in humans by cholecystokinin.
    Liddle RA; Morita ET; Conrad CK; Williams JA
    J Clin Invest; 1986 Mar; 77(3):992-6. PubMed ID: 3949984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of CCK-8 on basal and meal-stimulated somatostatin in the baboon.
    Figlewicz DP; Woods SC; Porte D; Taborsky GJ
    Peptides; 1986; 7(5):771-4. PubMed ID: 2879277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of CCK-8 and somatostatin-14 in control of food intake in dogs.
    Kalogeris TJ; Reidelberger RD; Mendel VE; Solomon TE
    Am J Physiol; 1989 Jul; 257(1 Pt 2):R15-20. PubMed ID: 2568759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraventricular insulin enhances the meal-suppressive efficacy of intraventricular cholecystokinin octapeptide in the baboon.
    Figlewicz DP; Sipols AJ; Seeley RJ; Chavez M; Woods SC; Porte D
    Behav Neurosci; 1995 Jun; 109(3):567-9. PubMed ID: 7662167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats.
    Reidelberger RD; Arnelo U; Granqvist L; Permert J
    Am J Physiol Regul Integr Comp Physiol; 2001 Mar; 280(3):R605-11. PubMed ID: 11171636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific adaptation of gastric emptying to diets with differing protein content in the rat: is endogenous cholecystokinin implicated?
    Shi G; Leray V; Scarpignato C; Bentouimou N; Bruley des Varannes S; Cherbut C; Galmiche JP
    Gut; 1997 Nov; 41(5):612-8. PubMed ID: 9414966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin inhibits gastric motility and emptying via a capsaicin-sensitive vagal pathway in rats.
    Raybould HE; Taché Y
    Am J Physiol; 1988 Aug; 255(2 Pt 1):G242-6. PubMed ID: 3136661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of endogenous opiates in regulation of gastric emptying of fat test meals in mice.
    Fioramonti J; Fargeas MJ; Bueno L
    Am J Physiol; 1988 Aug; 255(2 Pt 1):G158-61. PubMed ID: 3407774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action of the cholecystokinin antagonist L364,718 on gastric emptying in the rat.
    Green T; Dimaline R; Peikin S; Dockray GJ
    Am J Physiol; 1988 Nov; 255(5 Pt 1):G685-9. PubMed ID: 3056036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin suppresses food intake by inhibiting gastric emptying.
    Moran TH; McHugh PR
    Am J Physiol; 1982 May; 242(5):R491-7. PubMed ID: 7081475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.